Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): appendix a - provisional matrix of stakeholders
|
Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): appendix a - provisional matrix of stakeholders
13 October 2014 (100.37 Kb 29 sec) |
This page was last updated: 10 October 2014